Malaria: Exists throughout the year in the whole country. Recommended prophylaxis: Mefloquine.
 
Visas: Required by all. Multiple-entry visas: 90 days from date of issue. Transit visas: 7 days from date of issue. Visas can sometimes also be obtained at the airport or in the country.
 

Malaria: From November to May/June in the northern regions and in Omaheke and Otjozondjupa. Also throughout the year along the Kavango and Kunene rivers. Recommended prophylaxis: Chloroquine plus Proguanil.
 
Visas: Required by all except the following: nationals of EU countries (except nationals of Greece who do require a visa); British, Australian, Canadian, USA and Japanese; nationals of Angola, Botswana, Brazil, Cuba, Iceland, Kenya, Lesotho, Liechtenstein, Malawi, Malaysia, Mozambique, New Zealand, Norway, Russian Federation, Singapore, South Africa, Swaziland, Switzerland, Tanzania, Zambia and Zimbabwe. 

 

Malaria: Exists in northern Mpumalanga (including the Kruger National Park), Northern Province and north-eastern KwaZulu-Natal as far south as the Tugela river. Recommended prophylaxis: Mefloquine.
 
Visas: Required by all except the following : British, Other EU, Australian, Canadian, USA and Japanese for visits of up to 90 days; nationals of Iceland, Liechtenstein, New Zealand, Norway and Switzerland for visits of up to 90 days; nationals of Argentina, Brazil, Chile, Ecuador, Israel, Jamaica, Malta, Paraguay, St Helena, Swaziland, Uruguay and Venezuela for visits of up to 90 days; nationals of Antigua & Barbuda, Barbados, Belize, Benin, Bolivia, Botswana, Cape Verde, Costa Rica, Cyprus, Gabon, Guyana, Hong Kong (SAR), Hungary, Jordan, Korea (Rep. of), Lesotho, Macau (SAR), Malawi, Malaysia, Maldives, Mauritius, Mexico, Namibia, Peru, Seychelles, Singapore, Slovak Republic, Thailand, Turkey, Zambia and Zimbabwe for visits of up to 30 days; transit passengers continuing their journey by the same or first connecting aircraft provided holding onward or return documentation and not leaving the airport.
 

Malaria: In all lowveld areas (mainly Big Bend, Mhlume, Simunye and Tshaneni). Recommended prophylaxis in risk areas: Mefloquine.
 
Visas: Required by all except the following for stays of up to 60 days: British, other EU, Australian, Canadian, USA and Japanese; nationals of Commonwealth countries (except nationals of Antigua & Barbuda, Bangladesh, Belize, Brunei, Cameroon, Dominica, India, Kiribati, Maldives, Mauritius, Mozambique, Nigeria, Pakistan, Sri Lanka, St Kitts & Nevis, St Lucia, St Vincent & the Grenedines, Tuvalu and Vanuatu who do require a visa); nationals of Iceland, Israel, Liechtenstein, Poland, San Marino, Switzerland, Turkey and Uruguay.
 

Malaria: Throughout the year in the whole country. Recommended prophylaxis: Mefloquine.
 
Visas: A bonafide tourist, who is travelling on a pre-arranged package tour with a foreign tour operator, in conjunction with a local tour operator in Zambia, will be issued a fee-waived visa for a stay of no longer than 14 days. The fee-waived visa will be issued at any port of entry to Zambia.
In other cases, visas are required by all except the following for stays of up to 30 days: British tourists travelling in organised tour groups pre-arranged through tour operators in conjunction with registered local Zambian tour operators; nationals of Ireland (all other EU nationals do require a visa); Australian, Canadian; nationals of Romania and Yugoslavia (Serbia and Montenegro); nationals of Commonwealth countries (except nationals of Bangladesh, Gambia, Ghana, India, Mozambique, Nigeria, Pakistan, Papua New Guinea, Sierra Leone, Sri Lanka and New Zealand who do require a visa); transit passengers continuing their journey by the same or first connecting aircraft within 24 hours provided holding valid onward or return documentation and not leaving the airport.
Note: British, Danish and Norwegian children travelling on their own passports do need a visa.
 

Malaria: Exists from November through June in areas below 1200m and throughout the year in the Zambezi valley. Recommended prophylaxis: Mefloquine.
 
Visas: Required by all except the following: nationals of Canada, Ireland, Sweden and the UK; nationals of Bahamas, Barbados, Bermuda, Botswana, Brunei, Fiji, Grenada, Guyana, Hong Kong, Jamaica, Kenya, Kiribati, Lesotho, Malawi, Malaysia, Maldives, Malta, Mauritius, Namibia, Nauru, Norway, St Kitts & Nevis, St Lucia, St Vincent and the Grenadines, Samoa, Singapore, Solomon Islands, Swaziland, Tanzania, Tonga, Trinidad & Tobago, Tuvalu, Uganda, Vanuatu, Zambia; passengers continuing their journey to a third country within 6 hours by the same or connecting flight, provided holding tickets with reserved seats and documents for onward travel and not leaving the transit area.

Note: Nationals of the following countries may obtain visas on arrival in Zimbabwe, provided holding tickets and documents for return or onward travel and sufficient funds for their stay: Argentina, Australia, Austria, Belgium, Brazil, Chile, Cook Islands, Denmark, Dominica, Dominican Republic, Finland, France, Germany, Ghana, Iceland, Indonesia, Israel, Italy, Japan, Korea, Kuwait, Liechtenstein, Luxembourg, Monaco, Netherlands, New Zealand, Papua New Guinea, Poland, Seychelles, Spain, Switzerland, USA and Vatican City.
 

Malaria: Malaria risk, predominantly in the malignant falciparum form, exists throughout the year in all areas below 2000m (6562ft). Highly chloroquine-resistant falciparum is reported. No malaria risk exists in Addis Ababa.

Visas: Required by all except the following: nationals of Djibouti and Kenya for stays of up to three months and transit passengers continuing to a third country within 12 hours, provided not leaving the airport and holding valid travel documents for onward destination.

 

Malaria: Throughout the year in the whole country. There is usually less risk in Nairobi and in the highlands (above 2500m/8200ft) of the Central, Eastern Nyanza, Rift Valley and Western Provinces. The predominant falciparum strain has been reported as highly resistant to chloroquine and resistant to sulfadoxine/pyrimethamine. Recommended prophylaxis: Mefloquine.

Visas: Required by all except nationals of the following: nationals of Commonwealth countries for stays of up to three months except nationals of Great Britain, Australia, Antigua & Barbuda, Bangladesh, Belize, Cameroon, Guyana, India, New Zealand, Nigeria, Pakistan, Sri Lanka, St Kitts & Nevis and Trinidad & Tobago who do require a visa; nationals of Ethiopia, San Marino, Turkey and Uruguay; nationals of Malaysia if staying less than 30 days; all holders of a re-entry pass to Kenya; transit passengers continuing their journey by the same or first connecting aircraft provided holding valid onward or return documentation and not leaving the airport .
 

Malaria: Throughout the year in the whole country and is highest in coastal areas. Recommended prophylaxis: Mefloquine.

Visas: Required by all except the following: transit passengers continuing their journey by the same or first connecting aircraft within 24 hours provided holding onward or return documentation and not leaving the airport.
 

Malaria: Throughout the year in the whole country. The predominant malignant falciparum strain is reported to be highly resistant to chloroquine and resistant to sulfadoxine-pyrimethamine. Recommended prophylaxis: Mefloquine

Visas: Required by all except nationals of the following: nationals of EU countries except nationals of Austria, Czech republic, Estonia, Greece, Hungary, Latvia, Lithuania, Poland, Slovak Republic and Slovenia, who do need a visa; nationals of Commonwealth countries except Cameroon, India, Nigeria and Pakistan who do require a visa; nationals of Canada, Island, Israel, Japan, Madagascar, Norway, San Marino, USA and Zimbabwe; foreign nationals in transit who are continuing their journey by the same or connecting aircraft to a third country within 24 hours. Permission must be obtained to leave the airport, however.
 

Malaria: Malaria risk, predominantly in the malignant falciparum form, exists all year throughout the country below 1800m (5906ft). The strain is reported to be highly resistant to chloroquine and sulfadoxine-pyrimethamine.

Visas: Required by all nationals except the following for stays of up to three months (who are issued with a visitor's pass on arrival): Antigua & Barbuda, Barbados, Belize, Bermuda, Botswana, Brunei, Cyprus, Dominica, Grenada, Guyana, Jamaica, Kenya, Kiribati, Lesotho, Malaysia, Malawi, Maldives, Malta, Mauritius, Namibia, Nauru, St Kitts & Nevis, St Lucia, St Vincent & the Grenadines, São Tomé e Príncipe, Seychelles, Singapore, Solomon Islands, Swaziland, Tonga, Tuvalu, Uganda, Vanuatu, Zambia and Zimbabwe. Note: Nationals who do not require visas for stays of up to three months may still need entry permit clearance, except nationals of Kenya and Uganda. All other nationals must obtain visas in advance except nationals coming from a country where there is no Tanzania Embassy, High Commission or Consulate to issue a visa. In this case, these nationals may obtain a visa on arrival at one of the following four main entry points, provided all immigration and health requirements are met: Dar es Salaam International Airport, Kilimanjaro International Airport, Namanga Entry Point (Tanzania-Kenya border crossing) and Zanzibar International Airport.